Weekly movers: Hits and misses in the large cap space during the week!

General Insurance Corporation of India-

The shares of General Insurance Corporation of India surged by 5.5% in the last 5 trading sessions. This surge came in the backdrop of a board meeting which was scheduled on December 21, 2022, to consider and approve general matters of the Corporation. Apart from this, General Insurance Corporation of India has not made any significant announcements of late. Hence, the rally in the share price could be driven by the market forces.

Lupin Ltd- 

On Wednesday, the company announced the launch of its Regional Reference Laboratory in Indore, Madhya Pradesh, as part of its expansion in Central India. On the same day, the company reported that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Brivaracetam Tablets in the following strengths- 10 mg, 25 mg, 50 mg, 75 mg and 100 mg. The Brivaracetam Tablets are a generic equivalent of Briviact Tablets, available in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg and are produced by UCB Inc. Today, the company reported a spurt in trading volume by more than 4.59 times.

Divi's Laboratories Ltd-

In the last 5 trading sessions, the shares of Divi's Laboratories Ltd gained by 5.2 %. It should be noted that Divi's Laboratories Ltd has not made any significant announcements of late. Hence, the rally in the share price could be driven by the market forces. Today, the company reported a spurt in trading volume by more than 5.58 times.